US crypto ETF inflows cool after $3.3B week but streaks hold
US spot crypto exchange-traded fund (ETF) attracted about $64.8 million on inflows continued to cool on Monday, down roughly 80% from Friday after a strong week of buying.
SoSoValue data showed US spot Bitcoin (BTC) ETFs led Monday’s inflows with $31.07 million, followed by $17.1 million for Ether (ETH) ETFs. Solana (SOL) funds recorded $12.7 million, while XRP (XRP) ETFs drew $3.96 million.
The four categories attracted roughly $330.8 million on Friday. Bitcoin funds drew $134.47, while Ether took in $86.95 million, Solana $86.7 million and XRP $22.65 million.
The broad cooldown across US spot crypto ETFs followed a week of strong demand, when the same four ETF categories attracted more than $3.3 billion combined. Bitcoin ETFs led last week’s inflows with $2.39 billion, followed by Ether at $690 million, Solana at $188 million and XRP at $75.6 million. Zcash ETFs added about $35 million last week before posting an $8.1 million outflow on Monday.
Crypto ETF inflow streaks continue despite slowdown
While Monday’s inflows were substantially smaller, all four categories remained in positive territory and continued their inflow streaks.
Monday extended Bitcoin ETFs’ net inflow streak to eight consecutive trading sessions. The funds have attracted about $3 billion over the period, including a 2026 high of nearly $1 billion on Sept. 21.
Ether ETFs recorded their seventh consecutive positive trading session. Farside data shows BlackRock’s iShares Ethereum Trust accounting for $15.4 million of Monday’s $17.1 million total, while 21Shares’ TETH added $1.7 million.
Solana ETFs extended their net inflow streak to seven consecutive trading sessions on Monday, with Bitwise’s BSOL accounting for most of the day’s inflows. XRP ETFs posted a fifth straight positive session, with Canary Capital’s XRPC attracting the entire $3.96 million category inflow.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation
Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.
The United States relaxes fuel standards, significantly reducing technology costs for automakers: General Motors (GM.US) is expected to save 20.4 billion dollars, and the price per vehicle may drop by nearly 1,300 dollars.
The United States has relaxed fuel economy standards, allowing automakers to save $60.6 billions in technology costs by 2031, with the cost per vehicle expected to decrease by $1,289.
